Seroepidemiological surveillance study of COVID-19 (version 1) [COVID-19]

• Research type

  Research Study

• Full title

  Seroepidemiological surveillance study of COVID-19 in the Cambridge University Hospitals NHS Foundation Trust (CUHNFT)

• IRAS ID

  283624

• Contact name

  Stephen Baker

• Contact email

  sgb47@medschl.cam.ac.uk

• Sponsor organisation

  The sponsors is Cambridge University Hospital NHS Foundation Trust and the University of Cambridge

• Duration of Study in the UK

  1 years, 0 months, days

• Research summary

  To estimate the rate of seroconversion to COVID-19 in the cambridgeshire area we aim to collect resuidual serum from the biocehemistry laboratory weekly for a period of 9 months. This serum will be age stratified and subjected to an ELISA to estimate the proportion of people with a proective antibody titre.

• REC name

  London - Queen Square Research Ethics Committee

• REC reference

  20/HRA/2328

• Date of REC Opinion

  7 May 2020

• REC opinion

  Further Information Favourable Opinion